<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>精神病患者的赛洛西宾治疗获得法律框架 Psilocybin Treatment for Mental Health Gets Legal Framework</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">Psilocybin Treatment for Mental Health Gets Legal Framework<br/>精神病患者的赛洛西宾治疗获得法律框架 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2020-12-11 20:41:34</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2020/12/bc001b59e5ad6d13294f8293a1e9d9a8.jpg"><img src="http://img2.diglog.com/img/2020/12/bc001b59e5ad6d13294f8293a1e9d9a8.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>Oregon made history on November 3, becoming not just the first U.S. state to legalize psilocybin, the psychoactive compound in “magic mushrooms,” but also the first jurisdiction in the world to lay out plans for regulating the drug’s therapeutic use.</p><p>俄勒冈州于11月3日创造了历史，不仅成为美国第一个使psilocybin（“神奇蘑菇”中的精神活性化合物）合法化的州，而且成为世界上第一个制定规范药物治疗用途计划的州。</p><p> The next day, on the opposite coast, Johns Hopkins University researchers published results from the  first randomized controlled trial of treating major depressive disorder with synthetic psilocybin. Their study, published in  JAMA Psychiatry, found 71 percent of patients experienced a “clinically significant response” (an improvement that lasted at least four weeks after treatment). And 54 percent met the criteria for total “remission of depression.”</p><p> 第二天，在相反的海岸，约翰霍普金斯大学的研究人员发表了第一项用合成的倍半孢菌素治疗重度抑郁症的随机对照试验的结果。他们的研究发表在《美国医学会杂志》（JAMA Psychiatry）上，发现71％的患者经历了“临床上显着的反应”（这种改善在治疗后至少持续了四个星期）。 54％的人完全符合“缓解抑郁症”的标准。</p><p> At the U.S. federal level, psilocybin remains a completely prohibited  Schedule 1 Drug, defined by the Drug Enforcement Administration as having “no currently accepted medical use and a high potential for abuse.” But the state-level ballot measure and positive study results broaden the legal circumstances and settings in which the potent psychedelic can be used for mental health therapy.</p><p> 在美国联邦一级，psilocybin仍然是完全禁止使用的附表1药物，由美国药物管制局（Drug Enforcement Administration）定义为“目前没有被接受的医疗用途，并且极有可能被滥用”。但是，国家级的选票措施和积极的研究结果拓宽了有效的迷幻剂可用于心理健康治疗的法律环境和设置。</p><p> “Our goal was to move psilocybin out of the medical framework so we could provide access to  anyone who might safely benefit,” meaning to allow its use by counseling therapists and not just by doctors in a hospital, says therapist Tom Eckert, co-author of the Oregon Psilocybin Therapy Ballot Measure, which passed with more than  1.2 million votes (55.7 percent). Although Oregon is not the first place in the U.S. to loosen restrictions on psilocybin—the cities of Oakland, Denver, Ann Arbor and Washington, D.C., voted in the past two years to effectively decriminalize the drug—it is the first to offer a framework for legal therapeutic use. “This is very different from decriminalization, which only seeks to lower the penalties for possession,” Eckert notes. “We want to bring this therapy out from the underground and into [safe therapeutic environments].”</p><p> 治疗学家汤姆·埃克特（Tom Eckert）表示：“我们的目标是将psilocybin移出医疗框架，以便我们为可能安全受益的任何人提供治疗途径。”这意味着可以通过咨询治疗师而不是医院的医生来使用它。俄勒冈州的赛洛西宾疗法投票措施获得通过，票数超过120万（55.7％）。尽管俄勒冈州不是美国第一个放宽对psilocybin的限制的地方-奥克兰，丹佛，安阿伯和华盛顿特区等城市在过去两年中投票通过有效地使该药物非刑事化，但它是第一个提供框架的国家用于合法的治疗用途。埃克特指出：“这与非刑事化大相径庭，非刑事化只是为了降低占有的刑罚。” “我们希望将这种疗法从地下带入[安全的治疗环境]。”</p><p> Such use will be tightly regulated, however: only licensed therapists and manufacturers will be allowed to grow the mushrooms or extract psilocybin from them, or to synthetically produce the drug, set up a psilocybin therapy center or provide therapy. There will be no dispensaries selling mushrooms for recreational use, as exist for cannabis in California and 15 other states. People must be over 21 to receive the drug, and may only consume it at a licensed facility with a certified therapist present. And Oregon will not be opening any legal psilocybin therapy centers until 2023 at the earliest, as the measure requires a two-year consultation with lawmakers.</p><p> 但是，将严格监管此类用途：只有获得许可的治疗师和制造商才能种植蘑菇或从蘑菇中提取psilocybin，或合成生产该药物，建立psilocybin治疗中心或提供治疗。像加州和其他15个州的大麻一样，将没有任何一家药房出售用于娱乐的蘑菇。人们必须年满21岁才能接受该药物，并且只能在有认证治疗师在场的有执照的设施中消费该药物。而且，俄勒冈州最早要到2023年才开放任何合法的psilocybin治疗中心，因为该措施需要与立法者进行为期两年的磋商。</p><p> The Oregon vote is the latest step in what many see as magic mushrooms’ march to become “the next marijuana”: a natural therapeutic and mood-altering compound gaining mainstream acceptance in a regulated market. Since 2015 psilocybin retreats have been allowed to operate in the Netherlands, where dozens of them cater to affluent tourists. Even there the drug exists in a legal gray area, however: psilocybin mushrooms are illegal, but “truffles” (clumps of the fungus’s subterranean root-like filaments) are legal.</p><p> 俄勒冈州的投票是许多人认为魔术蘑菇迈向“下一个大麻”的最新一步：一种天然的治疗和改变情绪的化合物，在规范市场上获得了主流的接受。自2015年以来，psilocybin静修间已被允许在荷兰开展活动，其中数十个迎合富裕游客的需求。但是，即使该药物在合法的灰色地带也存在：psilocybin蘑菇是非法的，但“松露”（真菌的地下根状细丝团）是合法的。</p><p>  The potential benefits of psilocybin, LSD and other psychedelics were widely explored by psychiatrists in the 1950 and 1960s, before such drugs leaked from the lab and were embraced by the counterculture. A subsequent backlash led to a strict prohibition of legitimate research for the next four decades. But in recent years, a handful of dogged psychiatrists have revived the field. A Johns Hopkins  2006 double-blind study (meaning neither trial participants nor researchers knew if a subject was receiving psilocybin or placebo), published in the journal  Psychopharmacology, demonstrated that psilocybin could give healthy volunteers “experiences having substantial and sustained personal meaning.”</p><p>  精神病学家在1950和1960年代广泛探索了psilocybin，LSD和其他迷幻药的潜在益处，然后这些药物从实验室泄漏出来并被反文化所接受。随后的强烈反对导致在接下来的四个十年中严格禁止合法研究。但是近年来，少数顽固的精神科医生使该领域恢复了活力。约翰霍普金斯大学（Johns Hopkins）在2006年进行的一项双盲研究（意味着试验参与者和研究人员都不知道受试者是否正在接受psilocybin或安慰剂），证明psilocybin可以为健康的志愿者提供“具有实质性和持续性个人意义的经验”。 </p><p> “What is different about psilocybin, compared to other mood-altering drugs or pharmaceuticals, is the enduring meaning and belief changes that can occur. People feel ‘reorganized’ in a way they don’t with other drugs,” says Johns Hopkins neuropharmacologist Roland Griffiths, lead author of the initial 2006 study as well as the latest one on depression. “It’s almost like reprogramming the operating system of a computer.” Griffiths now leads the new, $17 million-funded  Center for Psychedelic and Consciousness Research at Johns Hopkins Medicine.</p><p>“与其他改变情绪的药物或药物相比，psilocybin的不同之处在于可能会发生持久的含义和信念变化。人们以与其他药物不同的方式感到“重组”，”约翰斯·霍普金斯大学神经药理学家罗兰·格里菲思斯（Roland Griffiths）说，他是2006年最初的研究以及最新的抑郁症研究的主要作者。 “这就像重新编程计算机的操作系统一样。”格里菲斯（Griffiths）现在领导约翰霍普金斯大学医学中心（Johns Hopkins Medical）斥资1,700万美元成立的新的迷幻与意识研究中心。</p><p> Dozens of other scientific reports in the past 15 years have built on the 2006 study, demonstrating psilocybin’s helpfulness for a variety of mental health conditions. In  a 2016 paper in the  Journal of Psychopharmacology, Griffiths and his team found that more than 80 percent of patients with a terminal cancer diagnosis experienced a “significant decrease in depressed mood and anxiety” after psilocybin combined with psychotherapy. In the same year, other researchers published the first study demonstrating psilocybin’s potential to alleviate “treatment-resistant depression” that was not relieved by mainstream antidepressants. British researchers at Imperial College London described in   The Lancet Psychiatry the “marked and sustained improvements” in 12 patients suffering from this form of depression. This study, however, had no control (placebo) group. The latest randomized controlled trial from Johns Hopkins tested the drug in a double-blind study on 24 people suffering from major depressive disorder, which affects an estimated  300 million people worldwide. Roughly 20 percent of Americans will experience this form of depression at some point in their lives; by comparison, treatment-resistant depression is estimated to affect fewer than 5 percent.</p><p> 在过去15年中，数十项其他科学报告都建立在2006年的研究基础之上，证明了psilocybin对多种精神健康状况的帮助。 Griffiths和他的团队在2016年发表于《心理药理学杂志》上的一篇论文中发现，超过80％的患有晚期癌症诊断的患者，在倍半霉素结合心理治疗后经历了“情绪低落和焦虑明显降低”。同年，其他研究人员发表了第一项研究，证明了psilocybin可以缓解“抗治疗性抑郁症”的潜力，而主流抗抑郁药并不能缓解这种情况。伦敦帝国理工学院的英国研究人员在《柳叶刀精神病学》（The Lancet Psychiatry）中描述了12例患有这种抑郁症的患者的“显着且持续的改善”。但是，该研究没有对照组（安慰剂）。约翰·霍普金斯大学（Johns Hopkins）的最新随机对照试验在一项针对24名患有严重抑郁症的人的双盲研究中对该药进行了测试，该病影响全球约3亿人。大约有20％的美国人在生活中的某个时候会经历这种形式的抑郁。相比之下，估计抗治疗性抑郁症的影响不到5％。</p><p> In 2019 the U.S. Food and Drug Administration granted  “breakthrough” status to a company called Compass Pathways to study the use of psilocybin—in conjunction with psychotherapy—for treatment-resistant depression. This means the FDA recognises that the research “ demonstrates the drug may have substantial improvement on at least one clinically significant endpoint over available therapy,” and that research and development will be “expedited.”</p><p> 2019年，美国食品药品监督管理局授予名为Compass Pathways的公司“突破性”地位，以研究将psilocybin与心理治疗结合用于治疗难治性抑郁症。这意味着FDA认识到该研究“证明该药物在至少一个具有临床意义的终点上可能比现有疗法有实质性改善”，并且研发将“加速”。</p><p> “I welcome the broadening of the indications, because I think psilocybin is likely to be effective in a range of disorders,”  says David Nutt, author of the initial 2016 study on psilocybin and depression, and director of the neuropsychopharmacology unit in the division of brain sciences at Imperial College London. “However, it is critical that we have proper screening to protect people who might be vulnerable due to psychotic predispositions.”</p><p> “我欢迎拓宽适应症的使用范围，因为我认为psilocybin可能对多种疾病有效”，David Nutt是2016年针对psilocybin和抑郁症进行的初步研究的作者，同时也是神经心理药理学部门的负责人伦敦帝国理工学院的脑科学。 “但是，至关重要的是，我们必须进行适当的筛查，以保护可能因精神病易感性而受到伤害的人们。”</p><p> Rachel Aidan, a professional therapist and CEO of Synthesis Group, a Netherlands psilocybin retreat center now looking to expand operations to Oregon, agrees. “As excited as we all are about the power of these compounds, the reality is that they are NOT for everyone,” she says. “Right now we just need to keep our heads down to learn from the situation in Oregon, and plan carefully for the future so we don’t rush into legalization. We don’t want to recreate the 1960s and the backlash that ensued.”</p><p> Rachel Aidan是专业的治疗师兼综合小组（Synthesis Group）的首席执行官，该综合小组是荷兰的psilocybin撤退中心，目前正寻求将业务扩展到俄勒冈州。她说：“我们对这些化合物的功效感到非常兴奋，但事实是它们并不适合所有人。” “现在，我们只需要保持低调，向俄勒冈州的局势学习，并为未来做好周密的计划，这样我们就不会急于合法化。我们不想重现1960年代和随之而来的反弹。”</p><p>  Because psilocybin is thought to be most effective when given in combination with psychotherapy, the cost (possibly involving a dozen or more hours of therapy sessions) could remain in the thousands of dollars for the near future—and even more if the treatment involves synthetic psilocybin. Nonetheless, many hope the latest study will lead to psilocybin treatment being viewed more as a first line of defense for depression, rather than a quirky option for people who are desperate after conventional treatments fail. Psilocybin appeals to many because of the treatment’s rapid and sustained effects, combined with the lack of unpleasant side effects such as weight gain and loss of libido, which are typically associated with widely prescribed SSRI antidepressants.</p><p>  由于psilocybin与心理疗法联合使用被认为是最有效的，因此在不久的将来，费用（可能涉及十几个小时或更长的治疗时间）可能仍在数千美元之内，如果治疗涉及合成的psilocybin，则成本甚至更高。 。尽管如此，许多人希望最新研究将使psilocybin治疗更多地被视为抑郁症的第一道防线，而不是对于那些在常规治疗失败后绝望的人的古怪选择。赛洛西宾之所以吸引许多人，是因为该疗法具有快速，持续的作用，并且缺乏令人不快的副作用，例如体重增加和性欲下降，这通常与广泛使用的SSRI抗抑郁药有关。</p><p> “This isn’t about selling people a box of pills. This is about exploring a new way to deal with depression by going into the underlying issues,” says Rosalind Watts, a psychologist who was formerly clinical lead on the psilocybin for depression study at Imperial College London. “It’s not that this is better than antidepressants—it’s just better for some people. Some people will still prefer antidepressants because they are simply more convenient. It just makes sense to have different options, and for us to understand that different things work for different people at different times.”</p><p> “这不是要给人们卖一盒药。这是关于通过探讨潜在问题来探索治疗抑郁症的新方法。”心理学家罗莎琳德·沃茨（Rosalind Watts）说道，他曾是伦敦帝国理工学院抑郁症研究的倍半胱氨酸的临床负责人。 “这并不是说它比抗抑郁药更好，而是对某些人来说更好。有些人仍然会更喜欢抗抑郁药，因为它们更方便。有不同的选择才有意义，让我们了解到，不同的事物在不同的时间对不同的人起作用。” </p><p> Watts has now left Imperial to operate as the  clinical director at Synthesis, where she works to develop psilocybin therapies outside of medical academia. “Rather than conduct more small trials,” she says, “I wanted to help set up something for people to access psilocybin therapy  now.”</p><p>瓦茨（Watts）现在已离开Imperial（帝国理工）出任综合（Synthesis）的临床总监，在那里她致力于在医学界之外开发出倍半霉素疗法。她说：“与其进行更多的小型试验，不如我想帮助建立一些使人们现在可以接受倍半霉素治疗的药物。”</p><p> Actions like this by clinicians around the world are nudging psilocybin from a fringe treatment toward mainstream medicine. As Rick Doblin, founder and executive director of the Santa Cruz, Calif.–based Multidisciplinary Association for Psychedelic Studies, puts it: “Our long term goal is mass mental health.”</p><p> 世界各地的临床医生都在采取这样的行动，将psilocybin从边缘治疗转向主流医学。正如总部位于加利福尼亚州圣克鲁斯的迷幻研究多学科协会的创始人兼执行董事里克·多布林（Rick Doblin）所言：“我们的长期目标是全面的心理健康。”</p><p> Johns Hopkins and Imperial researchers have already planned more psilocybin studies for a range of difficult-to-treat conditions, hoping to harness the drug’s ability to “unblock” people by shifting perspectives, catalyzing insights and changing problematic and habitual mindsets and behaviors. Studies on anorexia, obsessive-compulsive disorder, smoking cessation, opiate addiction and post-traumatic stress disorder are all in the works.</p><p> 约翰·霍普金斯大学和帝国研究人员已经针对一系列难以治疗的疾病计划了更多的倍半潮红素研究，希望通过改变观点，激发见解，改变有问题和习惯性的思维方式和行为，利用药物的“解禁”能力。对厌食症，强迫症，戒烟，鸦片成瘾和创伤后应激障碍的研究都在进行中。</p><p> Griffiths, however, is wary of efforts to rush the drug out from tightly regulated settings. “I’m sympathetic to people who are impatient, but we don’t want to end up in a situation where people underestimate the potential risks of using these compounds. They do have significant risks, such as panic, anxiety and dangerous behavior,” he says. “In Oregon, the devil is in the details in how things will unfold.”</p><p> 但是，格里菲思（Griffiths）对将药物赶出严格监管的环境保持警惕。 “我对急躁的人表示同情，但我们不想在人们低估使用这些化合物的潜在风险的情况下结束自己的生活。他们确实有严重的风险，例如恐慌，焦虑和危险行为。”他说。 “在俄勒冈州，魔鬼是如何发展的细节。” </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.scientificamerican.com/article/psilocybin-treatment-for-mental-health-gets-legal-framework/">https://www.scientificamerican.com/article/psilocybin-treatment-for-mental-health-gets-legal-framework/</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/患者/">#患者</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/treatment/">#treatment</a></button></div></div><div class="shadow p-3 mb-5 bg-white rounded clearfix"><div class="container"><div class="row"><div class="col-sm"><div><a target="_blank" href="/story/1039002.html"><img src="http://img2.diglog.com/img/2020/12/thumb_e3bc4677f5c663539c0afc42c2d6600c.png" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1039002.html">LeanTaaS利用AI最大限度地减少了医院和诊所的预约等待时间，筹集了1.3亿美元的D轮融资，使其总筹资额超过2.5亿美元 </a></div><span class="my_story_list_date">2020-12-11 8:2</span></div><div class="col-sm"><div><a target="_blank" href="/story/1037723.html"><img src="http://img2.diglog.com/img/2020/12/thumb_bc001b59e5ad6d13294f8293a1e9d9a8.jpg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1037723.html">精神病患者的赛洛西宾治疗获得法律框架 </a></div><span class="my_story_list_date">2020-12-4 23:48</span></div><div class="col-sm"><div><a target="_blank" href="/story/1037438.html"><img src="http://img2.diglog.com/img/2020/12/thumb_3bbcb337e0bff4c91594a234a211a1bb.jpg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1037438.html">美国首次推出阿尔茨海默氏症血液测试以用于临床 </a></div><span class="my_story_list_date">2020-12-4 20:28</span></div><div class="col-sm"><div><a target="_blank" href="/story/1037008.html"><img src="http://img2.diglog.com/img/2020/11/thumb_ac8b54ea865966ab80c923c8d2be768e.png" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1037008.html">Well Health使医疗保健组织通过短信，电子邮件，电话或实时聊天与患者联系，筹集了4500万美元的C轮融资，使总筹资额达到7500万美元</a></div><span class="my_story_list_date">2020-11-28 22:24</span></div></div></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>